12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

Marina Biotech, Tekmira Pharmaceuticals Inc. deal

Marina Biotech granted Tekmira a non-exclusive, worldwide license to develop and commercialize RNAi therapeutics using Marina Biotech's Unlocked Nucleobase Analog (UNA) technology for undisclosed indications. Marina...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >